Old Web
English
Sign In
Acemap
>
authorDetail
>
Cécile de Labareyre
Cécile de Labareyre
GlaxoSmithKline
Cancer
Medicine
Regimen
Pathology
Chemotherapy
3
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer
2015
Investigational New Drugs
Jaafar Bennouna
Marion Deslandres
Hélène Senellart
Cécile de Labareyre
Rodrigo Ruiz-Soto
Claire Wixon
Jeff Botbyl
A. Benjamin Suttle
Jean-Pierre Delord
Show All
Source
Cite
Save
Citations (16)
Rationale and delineation of a composite index of relative antitumoural efficacy (In-RATE)
2007
Critical Reviews in Oncology Hematology
Jean-Yves Blay
Serge Koscielny
J. Tredaniel
Bernard Asselain
François Goldwasser
Jean-Louis Misset
Cécile de Labareyre
Charles Hagège
Herve Bismut
Michel Marty
Show All
Source
Cite
Save
Citations (3)
Decision making process in oncology practice: Is the information available and what should it consist of?
2005
Critical Reviews in Oncology Hematology
J. Tredaniel
Jean-Yves Blay
François Goldwasser
Bernard Asselain
Serge Koscielny
Cécile de Labareyre
Nives Balogh
Herve Bismut
Jean-Louis Misset
M. Marty
Show All
Source
Cite
Save
Citations (5)
1